The Immune System in Liver Cancer: From Beginning to Progression-Reference-Cited by-同舟云学术

The Immune System in Liver Cancer: From Beginning to Progression

Published:2022 Issue: Volume: Page:
ISSN:2731-4561
Container-title:Interdisciplinary Cancer Research
language:
Short-container-title:

Author:

de Melo Silva Alex José,de Melo Gama Juliana Ellen,de Nascimento Cleonilde Maria,Lucena Jessica Paula,da Costa Cicero Jadson,Fernandes Camila Juliet Barbosa,Moura Danielle Maria Nascimento,Carvalho Helotonio,de Oliveira Sheilla Andrade

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/16833_2022_37

Reference135 articles.

1. Abe H, Kimura A, Tsuruta S, Fukaya T, Sakaguchi R, Morita R et al (2014) Aryl hydrocarbon receptor plays protective roles in ConA-induced hepatic injury by both suppressing IFN-γ expression and inducing IL-22. Int Immunol 26(3):129–137

2. Aleksandrova K, Boeing H, Nöthlings U, Jenab M, Fedirko V, Kaaks R et al (2014) Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology 60(3):858–871

3. Alexia C, Fallot G, Lasfer M, Schweizer-Groyer G, Groyer A (2004) An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem Pharmacol 68(6):1003–1015

4. Barry AE, Baldeosingh R, Lamm R, Patel K, Zhang K, Dominguez DA et al (2020) Hepatic stellate cells and Hepatocarcinogenesis. Front Cell Dev Biol 8:709

5. Cammà C, Di Marco V, Orlando A, Sandonato L, Casaril A, Parisi P et al (2005) Unità Interdipartimentale Neoplasie Epatiche (U.I.N.E) group. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol 42(4):535–540